Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model

This publication has 14 references indexed in Scilit:

• Comparison of the induction of apoptosis in human leukemic cell lines by 2′,2′-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside
  Leukemia Research, 1995
• Advanced breast cancer: a phase II trial with gemcitabine.
  Journal of Clinical Oncology, 1995
• Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol
  Cancer Chemotherapy and Pharmacology, 1995
• Kinetics of cisplatin‐induced apoptosis in murine mammary and ovarian adenocarcinomas
  International Journal of Cancer, 1995
• Phase II study of gemcitabine (2′,2′-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung c
  Annals of Oncology, 1994
• A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck
  Annals of Oncology, 1994
• 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines
  Biochemical Pharmacology, 1993
• The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer
  British Journal of Cancer, 1993
• Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3HKm mouse model systems
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Experimental studies on the combination of radiation and chemotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1978